XML 31 R19.htm IDEA: XBRL DOCUMENT
v3.21.2

EARNINGS PER SHARE | 9 Months Ended
--- | ---
Sep. 30, 2021
Earnings Per Share |
Earnings per share | NOTE 12 – EARNINGS PER SHARE ​ The following table illustrates the computation of basic and diluted earnings per share for the three and nine months ended September 30, 2021 and 2020 (in thousands, except per share data): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended | ​ | For the Nine Months Ended
​ | ​ | September 30, | ​ | September 30,
​ |  | 2021 |  | 2020 |  | 2021 |  | 2020
Numerator (basic and diluted): |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Net income | ​ | $ | 558,652 | ​ | $ | 527,252 | ​ | $ | 1,645,712 | ​ | $ | 1,359,357
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Denominator: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Weighted-average common shares outstanding – basic | ​ |  | 68,608 | ​ |  | 73,916 | ​ |  | 69,529 | ​ |  | 74,377
Effect of stock options (1) | ​ |  | 632 | ​ |  | 670 | ​ |  | 645 | ​ |  | 649
Weighted-average common shares outstanding – assuming dilution | ​ |  | 69,240 | ​ |  | 74,586 | ​ |  | 70,174 | ​ |  | 75,026
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Earnings per share: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Earnings per share-basic | ​ | $ | 8.14 | ​ | $ | 7.13 | ​ | $ | 23.67 | ​ | $ | 18.28
Earnings per share-assuming dilution | ​ | $ | 8.07 | ​ | $ | 7.07 | ​ | $ | 23.45 | ​ | $ | 18.12
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Antidilutive potential common shares not included in the calculation of diluted earnings per share: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Stock options (1) | ​ |  | 133 | ​ |  | 153 | ​ |  | 48 | ​ |  | 327
Weighted-average exercise price per share of antidilutive stock options (1) | ​ | $ | 467.03 | ​ | $ | 409.07 | ​ | $ | 502.49 | ​ | $ | 384.43
(1) | See Note 11 for further information concerning the terms of the Company’s share-based compensation plans.
​ For the three and nine months ended September 30, 2021 and 2020, the computation of diluted earnings per share did not include certain securities. These securities represent underlying stock options not included in the computation of diluted earnings per share, because the inclusion of such equity awards would have been antidilutive. ​ Subsequent to the end of the third quarter and through November 8, 2021, the Company repurchased 0.4 million additional shares of its common stock under its share repurchase program, at an average price of $618.44, for a total investment of 246.9 million.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration